東京慈恵会医科大学 腎臓・高血圧内科

腎臓・高血圧内科の歴史と概要、診療や研究などをご案内しております
HOME
腎臓・高血圧内科について
診療のご案内
教育・研究
入局希望の方へ

教育・研究

HOME > 教育・研究 > 研究業績 > 2014年研究業績

研究業績

2014年研究業績

Physician’s awareness of home blood pressure in the treatment of hypertensive patients with chronic kidney disease.

Sugano N, Kuriyama S, Hara Y, Takane K, Takahashi Y, Suetsugu Y, Yokoo T.
O J Nephrol 2014; 4(1): 28-36

Diffuse glomerular nodular lesion in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans.

Hara S1),Umeyama K2), Yokoo T, Nagashima H2)(2Meiji Univ.), Nagata M1)(1Univ. of Tsukuba)
PLoS One 2014; 9(3): e92219

Adipose Tissue-Derived Mesenchymal Stem Cells in Long-Term Dialysis Patients Display Downregulation of PCAF Expression and Poor Angiogenesis Activation.

Yamanaka S, Yokote S, Yamada A, Katsuoka Y, Izuhara L, Shimada Y, Omura N, Okano HJ, Ohki T, Yokoo T.
PLoS One 2014; 9(7): e102311

A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.

Kawamura T, Yoshimura M(Kanazawa Medical Centre), Miyazaki Y, Okamoto H, Kimura K1), Hirano K, Matsushima M, Utsunomiya Y, Ogura M, Yokoo T, Okonogi H, Ishii T, Hamaguchi A, Ueda H, Furusu A(Nagasaki Univ. Hosp.), Horikoshi S2), Suzuki Y2), Shibata T(Showa Univ.), Yasuda T1), Shirai S1)(1St. Marianna Univ.), Imasawa T(Chiba-East Hosp.), Kanozawa K(Saitama Univ.),Wada A(Osaka National Hosp.), Yamaji I(Teine Keijinkai Hosp.), Miura N3), Imai1H3) (3Aichi Medical Univ.), Kasai K(Fuji City Central Hosp.), Soma J(Iwate Prefectural Central Hosp.), Fujimoto S(Univ. of Miyazaki), Matsuo S(Univ. of Nagoya), TominoY2) (2Juntendo Univ.), The Special IgA Nephropathy Study Group
Nephrol Dial Transplant 2014; 29(8): 1546-53

A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.

Yokoyama K, Akiba T(Tokyo Woman,s Medical Univ.), Fukagawa M(Tokai Univ.Shool of Medicine), Nakayama M, Sawada K(Akita Univ.), Kumagai Y(Kitasoto Univ.), Chertow GM(Stanford Univ. Shool of Medicine), Hirakata H(Fukuoka Hosp.)
Nephrol Dial Transplant.  2014; 29(5): 1053-6

Keap1 inhibition attenuates glomerulosclerosis.

Miyazaki Y, Shimizu A, Pastan I(National Cancer, Institute), Taguchi K1), Naganuma E1), Suzuki T1), Hosoya T, Yokoo T, Saito A(Niigata Univ.), Miyata T1), Yamamoto M1)(1 Tohoku Univ.), Matsusaka T(Tokai Univ.)
Nephrol Dial Transplant 2014; 29(4): 783-91

Mice are unable to endogenously regenerate podocytes during the repair of immunotoxin-induced glomerular injury.

Miyazaki Y, Shimizu A, Ichikawa I1), Hosoya T, Pastan I(National Cancer Institute), Matsusaka T1)(1Tokai Univ.)
Nephrol Dial Transplant.  2014; 29(5): 1005-12

A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.

Maruyama Y, Taniguchi M1), Kazama JJ1), Yokoyama K, Hosoya T, Yokoo T, Shigematsu T(Wakayama Medical Univ.), Iseki K1), Tsubakihara Y1)(1Japanese Society for Dialysis Therapy)
Kidney Int.  2014; 29(8): 1532-8

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.

Matsuo H1), Nakayama A1), Sakiyama M1), Chiba T1), Shimizu S1), Kawamura Y1), Nakashima H1), Nakamura T1), Takada Y1), Oikawa Y(Toho Univ.), Takada T2), Nakaoka H(National Institute of Genetics), Abe J1), Inoue H1), Wakai K3), Kawai S3), Guang Y3), Nakagawa H3)(3Nagoya Univ.), Ito T(Self-Defense Forces Central Hosp.), Niwa K1), Yamamoto K(Kyushu Univ.), Sakurai Y1), Suzuki H2)(2The Univ. of Tokyo), Hosoya T, Ichida K, Shimizu T(Midorigaoka Hosp.), Shinomiya N1)(1National Defense Medical College))
Sci Rep 2014; 4: 3755

Common Dysfunctional Variants of ABCG2 Have Stronger Impact on Hyperuricemia Progression than Typical Environmental Risk Factors.

Nakayama A1), Matsuo H1), Nakaoka H(National Institute of Genetics), Nakamura T1), Nakashima H1), Takada Y1), Oikawa Y(Toho Univ.), Takada T2), Sakiyama M1), Shimizu S1), Kawamura Y1), Chiba T1), Abe J1), Wakai K3), Kawai S3), Okada R3), Tamura T3)(3Nagoya Univ.), Shichijo Y1), Akashi A1)(1National Defense Medical College), Suzuki H2)(2The Univ. of Tokyo), Ichida K, et al.
Sci Rep, 2014; 4: 5227-86

Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study

Nakayama M(Tohoku Univ.)(Fukushima Medical Univ.), Miyasaki M(Miyazaki Clinic), Honda K(Tokyo Women’s Medical Univ.), Kasai K(Fuji City General Hosp.), Tomo T(Oita Univ.) Nakamoto H(Saitama Medical Univ.), Kawanishi H(Tsuchiya General Hosp.); on behalf of the NEXT-PD study
Peritoneal Dialysis International 2014; 34(7): 766-74

Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load.

Zeniya M, Nakano M, Saeki C, Yokoyama K, Ishikawa T(Saiseikai Niigata Daini Hosp.), Takaguchi K(Kagawa Prefectural Central Hosp.), Takahashi H.
Hepatol Res. 2014; 44(10): E257-60

Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.

Nakao M, Yokoyama K, Yamamoto I, Matsuo N, Tanno Y, Ohkido I, Hayakawa H, Ikeda M, Yamamoto H, Hosoya T.
Ther Apher Dial. 2014; 18(1): 68-73

Is granular formulation of lanthanum carbonate more effective than chewable tablets?

Okamoto H, Haruhara K, Kamejima S, Mafune H, Manabe M, Kanzaki G, Mashiko H(Mashiko Hosp.), Yokoo T.
Ther Apher Dial. 2014; 18Suppl1: 23-7

Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats.

Yamada A, Yokoo T, Yokote S, Yamanaka S, Izuhara L, Katsuoka Y, Shimada Y, Shukuya A, Okano HJ, Ohashi T, Ida H.
Hum Cell 2014; 27(2): 59-67

A common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.

Sakiyama M1), Matsuo H1), Shimizu S1), Chiba T1), Nakayama A1), Takada Y1), Nakamura T1), Takada T2), Morita E3), Naito M3), Wakai K3), Inoue H1), Tatsukawa S1), Sato J1), Shimono K(Toho Univ.), Makino T(Nagoya City Univ.), Satoh T1), Suzuki H2)(2The Univ. of Tokyo), Kanai Y(Osaka Univ.), Hamajima N3)(3Nagoya Univ.), Sakurai Y1), Ichida K, Shimizu T(Midorigaoka Hosp.), Shinomiya N1)(1National Defense Medical College)
Hum Cell 2014; 27: 1-4

Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study.

Kuriyama S, Yokoyama K, Hara Y, Sugano N, Yokoo T, Hosoya T.
Clin Exp Nephrol. 2014; 18: 821-30

Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathy.

Miyazaki Y, Kawamura T, Joh K (Sendai Shakaihoken Hosp.), Okonogi H, Koike K, Utsunomiya Y, Ogura M, Matsushima M, Yoshimura M (Kanazawa Medical Center), Horikoshi S1), Suzuki Y1), Furusu A (Nagasaki Univ.), Yasuda T2), Shirai S2), Shibata T (Showa Univ.), Endoh M (Tokai Univ.), Hattori M3), Akioka Y3)(3Tokyo Woman's Hosp.) , Katafuti R (Higashifukuoka Medical Center), Hashiguchi A(Keio Univ.), Kimura K2)(2St Marianna Univ.), Matsuo S(Nagoya Univ.), Tomino Y1)(1Juntendo Univ.)
Clin Exp Nephrol 2014; 18(3): 475-80

The role of a low glomerular density and being overweight in the etiology of proteinuria in CKD patients without known glomerular diseases.

Okamoto H, Kawamura T, Okonogi H, Tsuboi N, Miyazaki Y, Yokoo T.
Clin Exp Nephrol 2014; 18(6): 911-7

Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line® during hemodialysis.

Sugano N, Yokoyama K, Kato N(Shinagawa Jin Clinic), Hara Y, Endo S, Mitome J, Kin T(Kawagoe Ekimae Clinic), Tokudome G, Kuriyama S, Hosoya T, Yokoo T.
Clin Exp Nephrol 2014; 18(6): 944-51

Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy.

Oshikawa J1), Toya Y1), Morita S1), Taguri M1), Hanaoka K, Hasegawa T, Kaizu K(Yokohama Central Hosp.), Kamata K(Kitasato Univ.), Kobayashi S2), Ohtake T2)(2Shonan Kamakura General Hosp.), Sato T5), Yasuda G1), Kimura K5)(5St. Marianna Univ.), Umemura S1) (1Yokohama City Univ.)
Clin Exp Hypertens 2014; 36(4): 244-50

Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat.

Iwai S1), Sakonju I1), Okano S1)(1 kitasata Univ.), Teratani T2), Kasahara N2), Yokote S, Yokoo T, Kobayash E2).(2Jichi Medical Univ.)
Transplant Proc. 2014; 46(5): 1578-84

Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis.

Takakura K, Koido S, Takahara A, Odahara S, Mitobe J, Matsudaira H, Tsukinaga S, Yukawa T, Matsumoto K, Nagatsuma K, Uchiyama K, Kajihara M, Ohkusa T, Tajiri H.
J Chemother 2014; 26(6): 369-72

An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation.

Honda K, Ando M1), Tsubokura M1), Yamashita T1), Akiyama H1),Sakamaki H1)(1Komagome Hosp.)
CEN Case Reports 2014; 3(1): 34-9

Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.

Yokoyama K, Hirakata H(Fukuoka Hosp.), Akiba T(Tokyo Women's Medical Univ.), Fukagawa M(Tokai Univ.), Nakayama M(Fukushima Medical Univ.), Sawada K(Akita Univ.), Kumagai Y(Kitasato Univ.), Block GA(Denver Nephrologists).
Clin J Am Soc Nephrol 2014; 9(3): 543-52

Common Variants of cGKII/PRKG2 are not Associated with Gout Susceptibility

Sakiyama M1), Matsuo H1), Chiba T1), Nakayama A1), Nakamura T1), Shimizu S1), Morita E1), Fukuda N1), Nakashima H1), Sakurai Y1), Ichida K, Shimizu T(Midorigaoka Hosp.), Shinomiya N1)(1National Defense Medical College)
J Rheumatol 2014; 41(7): 1395-7

A Common Variant of Organic Anion Transporter 4 (OAT4/SLC22A11) Gene is Associated with Renal Underexcretion Type Gout

Sakiyama M1), Matsuo H1), Shimizu S1), Nakashima H1), Nakayama A1), Chiba T1), Naito M2), Takada T3), Suzuki H3)(3The Univ. of Tokyo), Hamajima N2)(2Nagoya Univ.), Ichida K, Shimizu T(Midorigaoka Hosp.) Shinomiya N1)(1National Defense Medical college)
Drug Metab Pharmacokinet, 2014; 29(2): 208-10

Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.

Yokoyama K, Akiba T(Tokyo Women's Medical Univ.), Fukagawa M(Tokai Univ.), Nakayama M(Fukushima Medical Univ), Sawada K(Akita Univ.), Kumagai Y(Kitasato Univ.), Chertow GM( Stanford Univ.), Hirakata H(Fukuoka Hosp.)
Journal of Renal Nutrition 2014; 24: 261-7

Effects of Irbesartan on Serum Uric Acid Levels in Patients with Hypertension and Diabetes

Nakamura M(Tokyo Univ. of Pharmacy and Life Sciences), Sasai N(Sasai Clinic), Hisatome I(Tottori Univ.), Ichida K
Clin Pharmacol, 2014; 6: 79-86

Combined Therapy with Peritoneal Dialysis and Hemodialysis: A Multicenter Retrospective Observational Cohort Study in Japan.

Maruyama Y, Yokoyama K, Nakayama M, Higuchi C 1), Sanaka T1)(1Tokyo Women’s Medical Univ.), Tanaka Y2), Sakai K2), Mizuiri S2)(2Toho Univ.) , Otsuka Y, Kuriyama S, Maeba T (Asao Kidney Clinic), Iwasawa H3), Nakao T3) (3Tokyo Medical Univ), Hosoya T. EARTH (Evaluation of the Adequacy ofRenal replacement THerapy) study group.
Blood Purif 2014; 38: 149-53

Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid.

Kobayashi A, Yamamoto I, Nakada Y, Kidoguchi S, Matsuo N, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoyama K, Yokoo T.
Nephrology (Carlton). 2014; 19 Suppl 3: 37-41

Acute vascular rejection during antituberculosis therapy in a kidney transplant patient.

Nakada Y, Yamamoto I, Kobayashi A, Mafune A, Yamakawa T, Matsuo N, Tanno Y, Ohkido I, Yamamoto H, Yokoyama K, Yokoo T.
Nephrology (Carlton). 2014; 19 Suppl 3: 27-30

Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.

Furuya M, Yamamoto I, Kobayashi A, Nakada Y, Sugano N, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoyama K, Yokoo T.
Nephrology (Carlton). 2014; 19 Suppl 3: 31-4

Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient.

Tanabe N, Takane K, Yokoyama K, Tanno Y, Yamamoto I, Ohkido I, Yokoo T.
BMC Nephrol 2014; 15:151: 1-6

Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a Randomized trial.

Takahara Y1),Matsuda Y1),Takahashi S1)(1(Bayer Yakuhin),Shigematsu T(Wakayama Medical Univ.),Tsubakihara Y,Yamauchi A,Kuwahara T,Tsukamoto T,Hiramatsu M,Asano K, Yokoyama K,Shimizu H,Funabiki K,Tokita Y,Oobayashi T,Minakuchi J,Imanishi M,Shibuya Y,Ando R,Moriya H,Mochizuki T,Suzuki S,Inaguma D,Nakayama M, Sugawara A,Kikuchi H,Nasu N,Yaomuri T,Kadomatsu S,Aizawa N,Mikito T,Kurata K,Saito T,Nakamura M,Kawata T,Morio K,Kanai H,Nagae H,Takeoka H,Iwamoto T,Yasunaga C,Nakamura T,Tarnai H,Negi S:Lanthanum Carbonate Study Group.
Clin Nephrol 2014; 82(3): 181-90

Relationship between serum uric acid levels and muscle strength/volume: a new insight from a large-scale survey.

Kuriyama S, Nakano T, Maruyama Y, Sugano N, Takane K, Suetsugu Y, Takahashi Y, Kobayashi C, Nishio S, Takahashi D, Kidoguchi S, Ichida K, Ohno I, Hosoya T, Yokoo T.
Nihon Jinzo Gakkai Shi 2014; 56(8): 1260-9

A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab.

Haruhara K, Tsuboi N, Nakao M, Koike K, Fukui A, Miyazaki Y, Kawamura T, Ogura M, Yokoo T.
Nihon Jinzo Gakkai Shi 2014; 56(5): 600-5

Clinicopathological assessment of the nephron number.

Tsuboi N, Kanzaki G, Koike K, Kawamura T, Ogura M, Yokoo T.
Clin Kidney J 2014; 7(2): 107-14

Paracellular Route is the Major Urate Transport Pathway across the Blood-placental Barrier.

Uehara I1), Kimura T1), Tanigaki S1), Fukutomi T1), Sakai K1), Shinohara Y(Tokyo Univ. of Pharmacy and Life Sciences), Ichida K, Iwashita M1), Sakurai H1)(1Kyorin Univ.)
Physiol Rep, 2014; 2(5): 79-86

NPT1/SLC17A1 is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Variant Decreases the Risk of Renal Underexcretion Gout.

Chiba T1), Matsuo H1), Kawamura Y1), Nagamori S2), Nishiyama T2), Wei L2), Nakayama A1), Nakamura T1), Sakiyama M1), Takada T(The Univ. of Tokyo), Taketani Y(Univ. of Tokushima), Suma S3), Naito M3)(3Nagoya Univ.), Oda T1), Kumagai H1), Moriyama Y(Okayama Univ.), Ichida K, Shimizu T(Midorigaoka Hosp.), Kanai Y2)(2Osaka Univ.), Shinomiya N1)(1National Defense medical College).
Arthritis Rheumatol 2014; 67(1): 281-7

高リン血症を伴う血液透析中の慢性腎不全患者におけるビキサロマーの有効性および安全性の検討 ビキサロマー特定使用成績調査中間結果報告

秋澤 忠男(昭和大),栗原 怜(慶寿会さいたまつきの森クリニック),横山啓太郎,奥村 広之1),中村 一郎1),宗 政博1)(1アステラス製薬(株))
Therapeutic Research 2014; 35(5): 523-34

高尿酸血症治療薬Febuxostatの臨床的有用性

栗山 哲, 中野 知子1), 真家 健一1), 真島 香代子1), 田邉 智子1), 槙田 真由美1), 岡本 佳子1)(1東京国税局診療所), 横尾 隆
Therapeutic Research 2014; 35(7): 677-86

腹膜透析患者におけるCKD-MBD

横山 啓太郎
腎と透析 別冊 腹膜透析 2014; 77: 25-7

腹腔鏡でみた腹膜透析継続に伴う臓側腹膜の変化

丹野 有道
腎と透析 別冊 腹膜透析 2014; 77: 58-60

腹膜透析と血液透析での血清ヘプシジン濃度の比較と寄与因子の検討

丸山 之雄, 横山 啓太郎, 細谷 龍男, 横尾 隆
腎と透析 別冊 腹膜透析 2014; 77: 173-4

EPS症例の脈管形成について

栁沼 樹宏, 山本 泉
腎と透析 別冊 腹膜透析 2014; 77: 54-7

iOS端末(iPhone/iPad)を用いた腹膜透析支援システム(iPD)の使用実態について

田熊 亜希子,深堀 幸子,飯久保 素子,丹野 有道,大城戸 一郎,横山 啓太郎,細谷 龍男,横尾 隆
腎と透析 別冊 腹膜透析 2014; 77: 343-4

患者の生活スタイルに合わせたPD療法 元気が出るPD 導入前から在宅療養までの継続したサポート

渋江 育子
腎と透析 別冊 腹膜透析 2014; 77: 64-5

透析専門医の勤務実態と診療実態に関するアンケート調査報告

中山 昌明,岡田 一義(日本大),森石 みさき(中島土谷クリニック),熊谷 裕生(防衛医科大),横山 啓太郎,政金 生人(医療法人社団清永会透析事業部),安藤 亮一(武蔵野赤十字病院)
日本透析医学会雑誌 2014; 47(9): 521-7

維持血液透析の開始と継続に関する意思決定プロセスについての提言

秋澤 忠男(昭和大), 水口 潤(川島病院), 友 雅司(大分大), 政金 生人(矢吹病院), 渡邊 有三(春日井市民病院), 平方 秀樹(福岡赤十字病院), 岡田 一義(日本大), 山本 裕康, 井関 邦敏(琉球大), 酒井 謙(東邦大), 伊丹 儀人(日鋼記念病院), 鶴屋 和彦(九州大), 森 典子(静岡県立総合病院), 稲熊 大城(名古屋第二赤十字病院), 内田 明子(聖隷横浜病院), 大平 整爾(札幌北クリニック), 川口 良人, 井形 昭弘1), 岩尾 聰一郎1)(1日本尊厳死協会), 木村 利人(日本生命倫理学会), 宮本 高宏(全国腎臓病協議会), 小川 義龍(小川総合法律事務所): 日本透析医学会血液透析療法ガイドライン作成ワーキンググループ, 透析非導入と継続中止を検討するサブグループ
日本透析医学会雑誌 2014; 47(5): 269-85

腹部超音波検査で診断された痛風腎症例の特徴とABCG2遺伝子変異

西川 元、市田公美、大野岩男、細谷龍男、横尾 隆
痛風と核酸代謝 2014; 38(2): 117-23

慢性腎臓病における血清尿酸値と腎病理組織所見との関連

西川 元、山口雄一郎、大野岩男、細谷龍男、横尾 隆
痛風と核酸代謝 2014; 38(2): 109-16


教育・研究
教育研究活動
研究班
研究業績
国内外留学状況
大学院

サイトマップ
Copyright (C) Jikei University School of Medicine Division of Nephrology & Hypertension, Department of Internal Medicine All rights reserved.